293 related articles for article (PubMed ID: 19017279)
21. Investigation of the SH3BP2 gene mutation in cherubism.
Lee JY; Jung YS; Kim SA; Lee SH; Ahn SG; Yoon JH
Acta Med Okayama; 2008 Jun; 62(3):209-12. PubMed ID: 18596838
[TBL] [Abstract][Full Text] [Related]
22. Cherubism - new hypotheses on pathogenesis and therapeutic consequences.
Hyckel P; Berndt A; Schleier P; Clement JH; Beensen V; Peters H; Kosmehl H
J Craniomaxillofac Surg; 2005 Feb; 33(1):61-8. PubMed ID: 15694152
[TBL] [Abstract][Full Text] [Related]
23. [Gene mutation and expression of SH-3BP-2 in cherubism].
Li YW; Meng XM; Yu SF; Gao P
Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Apr; 44(4):227-31. PubMed ID: 19576004
[TBL] [Abstract][Full Text] [Related]
24. So-called hybrid central odontogenic fibroma/central giant cell lesion of the jaws. A report on seven additional cases, including an example in a patient with cherubism, and hypotheses on the pathogenesis.
Tosios KI; Gopalakrishnan R; Koutlas IG
Head Neck Pathol; 2008 Dec; 2(4):333-8. PubMed ID: 20614305
[TBL] [Abstract][Full Text] [Related]
25. [Genetic aspects of cherubism].
Brix M; Peters H; Ranfaing E; Ricbourg B
Rev Stomatol Chir Maxillofac; 2006 Apr; 107(2):105-8. PubMed ID: 16738517
[TBL] [Abstract][Full Text] [Related]
26. Novel mutation in the gene encoding c-Abl-binding protein SH3BP2 causes cherubism.
Lo B; Faiyaz-Ul-Haque M; Kennedy S; Aviv R; Tsui LC; Teebi AS
Am J Med Genet A; 2003 Aug; 121A(1):37-40. PubMed ID: 12900899
[TBL] [Abstract][Full Text] [Related]
27. Deactivating germline mutations in LEMD3 cause osteopoikilosis and Buschke-Ollendorff syndrome, but not sporadic melorheostosis.
Mumm S; Wenkert D; Zhang X; McAlister WH; Mier RJ; Whyte MP
J Bone Miner Res; 2007 Feb; 22(2):243-50. PubMed ID: 17087626
[TBL] [Abstract][Full Text] [Related]
28. Clinical and genetic analysis of patients with cherubism.
Machado RA; Pontes H; Pires FR; Silveira HM; Bufalino A; Carlos R; Tuji FM; Alves D; Santos-Silva AR; Lopes MA; Capistrano HM; Coletta RD; Fonseca FP
Oral Dis; 2017 Nov; 23(8):1109-1115. PubMed ID: 28644570
[TBL] [Abstract][Full Text] [Related]
29. [Cherubism: regression of the lesions and spontaneous bone regeneration].
Timosca GC
Rev Stomatol Chir Maxillofac; 1996; 97(3):172-7. PubMed ID: 8711332
[TBL] [Abstract][Full Text] [Related]
30. [Cherubism].
Brix M; Peters H; Lebeau J
Rev Stomatol Chir Maxillofac; 2009 Nov; 110(5):293-8. PubMed ID: 19836038
[TBL] [Abstract][Full Text] [Related]
31. Quantitative analysis of argyrophilic nuclear organizer regions in giant cell lesions of jaws.
Sadri D; Hejazi M; Jahanbani J; Forouzandeh A
J Oral Pathol Med; 2010 May; 39(5):431-4. PubMed ID: 20202088
[TBL] [Abstract][Full Text] [Related]
32. Cherubism allele heterozygosity amplifies microbe-induced inflammatory responses in murine macrophages.
Prod'Homme V; Boyer L; Dubois N; Mallavialle A; Munro P; Mouska X; Coste I; Rottapel R; Tartare-Deckert S; Deckert M
J Clin Invest; 2015 Apr; 125(4):1396-400. PubMed ID: 25705883
[TBL] [Abstract][Full Text] [Related]
33. SOS1: a new player in the Noonan-like/multiple giant cell lesion syndrome.
Hanna N; Parfait B; Talaat IM; Vidaud M; Elsedfy HH
Clin Genet; 2009 Jun; 75(6):568-71. PubMed ID: 19438935
[TBL] [Abstract][Full Text] [Related]
34. CD2AP mutations are associated with sporadic nephrotic syndrome and focal segmental glomerulosclerosis (FSGS).
Gigante M; Pontrelli P; Montemurno E; Roca L; Aucella F; Penza R; Caridi G; Ranieri E; Ghiggeri GM; Gesualdo L
Nephrol Dial Transplant; 2009 Jun; 24(6):1858-64. PubMed ID: 19131354
[TBL] [Abstract][Full Text] [Related]
35. WWOX expression in giant cell lesions of the jaws.
Amaral FR; Diniz MG; Bernardes VF; Souza PE; Gomez RS; Gomes CC
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Aug; 116(2):210-3. PubMed ID: 23849374
[TBL] [Abstract][Full Text] [Related]
36. Identification and characterization of two novel mutations that produce acute intermittent porphyria: A 3-base deletion (841-843delGGA) and a missense mutation (T35M).
De Siervi A; Weiss Cádiz DE; Parera VE; del C Batlle AM; Rossetti MV
Hum Mutat; 2000 Oct; 16(4):373. PubMed ID: 11013452
[TBL] [Abstract][Full Text] [Related]
37. [SH3BP2 heterozygous mutation amplifies macrophage inflammatory responses to infection in a mouse model of cherubism].
Deckert M; Prod'Homme V
Med Sci (Paris); 2015; 31(6-7):589-91. PubMed ID: 26152156
[No Abstract] [Full Text] [Related]
38. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
39. Variable expressivity familial cherubism: woman transmitting cherubism without suffering the disease.
Pérez-Sayáns M; Barros-Angueira F; Suárez-Peñaranda JÉ; García-García A
Head Face Med; 2013 Nov; 9():33. PubMed ID: 24382142
[TBL] [Abstract][Full Text] [Related]
40. The role of SH3BP2 in the pathophysiology of cherubism.
Reichenberger EJ; Levine MA; Olsen BR; Papadaki ME; Lietman SA
Orphanet J Rare Dis; 2012 May; 7 Suppl 1(Suppl 1):S5. PubMed ID: 22640988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]